Indications for Paxlovid
Assists in determining if Paxlovid (ritonovir-boosted nirmatrelvir) is appropriate therapy in a COVID positive adult patient.
INSTRUCTIONS
In the United States, Paxlovid (ritonovir-boosted nirmatrelvir), is currently availble under the Food and Drug Administration (FDA) Emergency Use Authorization (EUA). This drug status is subject to change.
When to Use
Diagnostic Result:
Please fill out required fields.